NEW YORK (GenomeWeb) – Guardant Health and Flatiron Health have announced a collaboration to integrate Guardant Health's liquid biopsy genomic testing results with clinical treatment and outcomes data using Flatiron's cloud-based information platform. 

The partners said this new ability to link patients' genomic data with their clinical records will hopefully support the accelerated development of targeted therapies for cancer by enabling life science companies to more quickly recruit and select patients for trials and to more easily follow subjects and their progress over time.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.